Solvonis Therapeutics PLC (SVNS) Share Price & Analysis

Open: 0.21
High: 0.21
Low: 0.20
Close: 0.20
Change: -0.01 (-7.32%)
Volume: 12,917,334

27 May 2026	12:00:01	Notice of Annual General Meeting
5 May 2026	07:00:18	CSO Speaks at National Research Meeting
29 Apr 2026	07:00:02	Final Results
22 Apr 2026	07:00:07	Appointment of Water Tower Research

19 May 2026	Annual Report for the year ended 31 December 2025
30 Apr 2025	Annual Financial Report 31 December 2024
14 May 2024	Annual Financial Report - 31.12.22

Dennis PurcellChair

1 yrs 9 mos

Anthony James TennysonCEO

2 yrs 1 mos

Ryan NeatesChief Financial Officer

–

Nicholas NelsonNon-Executive Director

2 yrs 3 mos

Renata CromeNon-Executive Director

1 yrs 3 mos

Industry: Health Care
Sector: Health Care
LEI: 2138005PH7OJRCRPUD88
Region: Europe
Admission date: 6 Jan 2022
Website: www.solvonis.com

Open: 0.21
High: 0.21
Low: 0.20
Close: 0.20
Change: -0.01 (-7.32%)
Volume: 12,917,334

27 May 2026	12:00:01	Notice of Annual General Meeting
5 May 2026	07:00:18	CSO Speaks at National Research Meeting
29 Apr 2026	07:00:02	Final Results
22 Apr 2026	07:00:07	Appointment of Water Tower Research

19 May 2026	Annual Report for the year ended 31 December 2025
30 Apr 2025	Annual Financial Report 31 December 2024
14 May 2024	Annual Financial Report - 31.12.22

Dennis PurcellChair

1 yrs 9 mos

Anthony James TennysonCEO

2 yrs 1 mos

Ryan NeatesChief Financial Officer

–

Nicholas NelsonNon-Executive Director

2 yrs 3 mos

Renata CromeNon-Executive Director

1 yrs 3 mos

Industry: Health Care
Sector: Health Care
LEI: 2138005PH7OJRCRPUD88
Region: Europe
Admission date: 6 Jan 2022
Website: www.solvonis.com

Shares in issue: 6,806,403,493
Total Voting Rights: 6,806,403,493

Last updated: 17 June 2026

ISIN: GB00BMD1Z199
Exchange: XLON
Market: Main Market
Market Segment: SSQ3
Market Sector: SQQ3
Security Description: Ordinary Shares of GBP0.001 each; fully paid
Listing Category: Equity shares (transition)

Shares in issue: 6,806,403,493
Total Voting Rights: 6,806,403,493

Last updated: 17 June 2026

ISIN: GB00BMD1Z199
Exchange: XLON
Market: Main Market
Market Segment: SSQ3
Market Sector: SQQ3
Security Description: Ordinary Shares of GBP0.001 each; fully paid
Listing Category: Equity shares (transition)

11 Apr 2026	Sunda Energy, Gelion, Coiled Therapeutics, Solvonis Therapeutics, Genflow Biosciences, Rome Resources - Small Cap Week in Review	Proactive Investors
8 Apr 2026	Solvonis Therapeutics CEO says dual US patent win strengthens PTSD pipeline	Proactive Investors

11 Apr 2026	Sunda Energy, Gelion, Coiled Therapeutics, Solvonis Therapeutics, Genflow Biosciences, Rome Resources - Small Cap Week in Review	Proactive Investors
8 Apr 2026	Solvonis Therapeutics CEO says dual US patent win strengthens PTSD pipeline	Proactive Investors

Solvonis Therapeutics PLC

Solvonis Therapeutics PLC

Price Chart

Recent RNS announcements

Annual Reports

Directors (6)

In the Press

Company details

Revenue Trend